Stay updated on CC-122/Nivolumab Combo in Unresectable HCC Clinical Trial
Sign up to get notified when there's something new on the CC-122/Nivolumab Combo in Unresectable HCC Clinical Trial page.

Latest updates to the CC-122/Nivolumab Combo in Unresectable HCC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision label updated from v3.4.1 to v3.4.2. The page content remains unchanged.SummaryDifference0.0%

- Check20 days agoChange DetectedThe page shows a revision update from v3.4.0 to v3.4.1, which is a minor software revision with no content changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check27 days agoChange DetectedThe page shows minor UI/label updates: a glossary toggle was added, QC-related labels were standardized, FEAR Act labeling updated, and the revision footer now shows Revision: v3.4.0 (replacing v3.3.4).SummaryDifference0.2%

- Check42 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4; no visible changes to content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedLocations section now shows a general Locations entry with California, Florida, New York, and Texas removed as separate blocks; revision updated to v3.3.3.SummaryDifference0.5%

- Check91 days agoChange DetectedRevision: v3.3.2 was added and v3.2.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to CC-122/Nivolumab Combo in Unresectable HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CC-122/Nivolumab Combo in Unresectable HCC Clinical Trial page.